{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T20:41:43Z","timestamp":1694464903071},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,6]]},"abstract":"<jats:p>The \u03b1<jats:sub>1<\/jats:sub>-adrenergic receptors (\u03b1<jats:sub>1<\/jats:sub>-ARs), which belong to a G protein-coupled receptor family, consist of three highly homologous subtypes known as \u03b1<jats:sub>1A<\/jats:sub>-ARs, \u03b1<jats:sub>1B<\/jats:sub>-ARs, and \u03b1<jats:sub>1D<\/jats:sub>-ARs. Our previous findings suggested that \u03b1<jats:sub>1A<\/jats:sub>-ARs are an important target for imipramine and electroconvulsive therapy. The current study sought to evaluate whether <jats:italic toggle=\"yes\">S<\/jats:italic>-(+)-niguldipine and B8805-033, two selective antagonists of \u03b1<jats:sub>1A<\/jats:sub>-ARs, can evoke antidepressant-like effects in the forced swim test in rats. Both compounds were administered at three time points (24, 5, and 1 h before testing), and the effects of three doses (2, 5, and 10 mg\/kg) of each compound were investigated. <jats:italic toggle=\"yes\">S<\/jats:italic>-(+)-Niguldipine produced no antidepressant-like effects other than a 14% reduction in immobility time at the highest dose. Although B8805-033 at a dose of 2 mg\/kg did not influence the rats\u2019 behavior, higher B8805-033 doses (5 and 10 mg\/kg) produced significant reductions in immobility time (approximately 42 and 44% vs. controls, respectively; <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.01). However, this effect was abolished by the concomitant administration of WAY100135, a serotonin receptor antagonist, suggesting that the observed antidepressant-like effects of B8805-033 are unrelated to \u03b1<jats:sub>1A<\/jats:sub>-ARs. Nevertheless, given the current dearth of selective \u03b1<jats:sub>1A<\/jats:sub>-AR agonists, the question of whether this particular subtype could be involved in antidepressant therapy mechanisms remains unresolved.<\/jats:p>","DOI":"10.1097\/fbp.0000000000000204","type":"journal-article","created":{"date-parts":[[2015,11,20]],"date-time":"2015-11-20T13:16:08Z","timestamp":1448025368000},"page":"397-401","source":"Crossref","is-referenced-by-count":1,"title":["A lack of \u03b11A-adrenergic receptor-mediated antidepressant-like effects of S-(+)-niguldipine and B8805-033 in the forced swim test"],"prefix":"10.1097","volume":"27","author":[{"given":"Grzegorz","family":"Kreiner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Roman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Zelek-Molik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Kowalska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irena","family":"Nalepa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230910","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0922-4106(89)90004-7","article-title":"(+)-Niguldipine binds with very high affinity to Ca2+ channels and to a subtype of \u03b11-adrenoceptors","volume":"172","author":"Boer","year":"1989","journal-title":"Eur J Pharmacol"},{"key":"R2-20230910","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0924-977X(02)00027-5","article-title":"Niguldipine impairs the protective activity of carbamazepine and phenobarbital in amygdala-kindled seizures in rats","volume":"12","author":"Borowicz","year":"2002","journal-title":"Eur Neuropsychopharmacol"},{"key":"R3-20230910","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00176837","article-title":"Is the forced swimming test a suitable model for revealing antidepressant activity?","volume":"94","author":"Borsini","year":"1988","journal-title":"Psychopharmacology (Berl)"},{"issue":"Pt 1","key":"R4-20230910","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1042\/bj3430231","article-title":"Truncated isoforms inhibit [3H]prazosin binding and cellular trafficking of native human \u03b11A-adrenoceptors","volume":"343","author":"Coge","year":"1999","journal-title":"Biochem J"},{"key":"R5-20230910","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.neubiorev.2005.03.009","article-title":"The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci Biobehav Rev"},{"key":"R6-20230910","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0028-3908(89)90097-X","article-title":"Dihydropyridine calcium channel antagonists as antidepressant drugs in mice and rats","volume":"28","author":"Czyrak","year":"1989","journal-title":"Neuropharmacology"},{"key":"R7-20230910","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00018-009-0174-4","article-title":"Subtypes of functional \u03b11-adrenoceptor","volume":"67","author":"Docherty","year":"2010","journal-title":"Cell Mol Life Sci"},{"key":"R8-20230910","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.brainres.2009.06.035","article-title":"\u03b11A- and \u03b11B-adrenergic receptors differentially modulate antidepressant-like behavior in the mouse","volume":"1285","author":"Doze","year":"2009","journal-title":"Brain Res"},{"key":"R9-20230910","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1124\/mol.111.073734","article-title":"Long-term \u03b11A-adrenergic receptor stimulation improves synaptic plasticity, cognitive function, mood, and longevity","volume":"80","author":"Doze","year":"2011","journal-title":"Mol Pharmacol"},{"key":"R10-20230910","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0006-3223(00)00935-5","article-title":"Neuronal plasticity and survival in mood disorders","volume":"48","author":"Duman","year":"2000","journal-title":"Biol Psychiatry"},{"key":"R11-20230910","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s002100100413","article-title":"In vitro and in vivo uroselectivity of B8805-033, an antagonist with high affinity at prostatic \u03b11A- vs. \u03b11B- and \u03b11D-adrenoceptors","volume":"363","author":"Eltze","year":"2001a","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"R12-20230910","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0014-2999(01)00835-4","article-title":"Failure of AH11110A to functionally discriminate between \u03b11-adrenoceptor subtypes A, B and D or between \u03b11- and \u03b12-adrenoceptors","volume":"415","author":"Eltze","year":"2001b","journal-title":"Eur J Pharmacol"},{"key":"R13-20230910","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0014-2999(93)90280-U","article-title":"WAY100135: a novel, selective antagonist at presynaptic and postsynaptic 5-HT1A receptors","volume":"237","author":"Fletcher","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"R14-20230910","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00345-009-0396-y","article-title":"Gene expressions and mechanical functions of \u03b11-adrenoceptor subtypes in mouse ureter","volume":"27","author":"Kobayashi","year":"2009","journal-title":"World J Urol"},{"key":"R15-20230910","first-page":"831","article-title":"Chronic treatment with citalopram does not affect the expression of \u03b11-adrenergic receptor (\u03b11-AR) subtypes","volume":"56","author":"Kreiner","year":"2004","journal-title":"Pol J Pharmacol"},{"key":"R16-20230910","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S1734-1140(11)70699-5","article-title":"Effects of the noradrenergic neurotoxin DSP-4 on the expression of \u03b11-adrenoceptor subtypes after antidepressant treatment","volume":"63","author":"Kreiner","year":"2011","journal-title":"Pharmacol Rep"},{"key":"R17-20230910","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/S0968-0896(00)00151-6","article-title":"Design, synthesis and biological evaluation of pyridine-phenylpiperazines: a novel series of potent and selective \u03b11a-adrenergic receptor antagonist","volume":"8","author":"Kuo","year":"2000","journal-title":"Bioorg Med Chem"},{"key":"R18-20230910","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0149-7634(94)90039-6","article-title":"Antidepressant-like behavioral effects of serotonin receptor agonists","volume":"18","author":"Lucki","year":"1994","journal-title":"Neurosci Biobehav Rev"},{"key":"R19-20230910","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/BF00241087","article-title":"Comparison of cloned and pharmacologically defined rat tissue \u03b11-adrenoceptor subtypes","volume":"350","author":"Michel","year":"1994","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"R20-20230910","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/sj.bjp.0702489","article-title":"Pharmacological analysis of the novel, selective \u03b11-adrenoceptor antagonist, KMD-3213, and its suitability as a tritiated radioligand","volume":"127","author":"Murata","year":"1999","journal-title":"Br J Pharmacol"},{"key":"R21-20230910","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0306-4522(91)90079-4","article-title":"Involvement of protein kinase C in the mechanism of in vitro effects of imipramine on generation of second messengers by noradrenaline in cerebral cortical slices of the rat","volume":"44","author":"Nalepa","year":"1991","journal-title":"Neuroscience"},{"key":"R22-20230910","first-page":"120","article-title":"The responsiveness of cerebral cortical adrenergic receptors after chronic administration of atypical antidepressant mianserin","volume":"19","author":"Nalepa","year":"1994","journal-title":"J Psychiatry Neurosci"},{"key":"R23-20230910","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0014-2999(02)01660-6","article-title":"Repeated imipramine and electroconvulsive shock increase \u03b11A-adrenoceptor mRNA level in rat prefrontal cortex","volume":"444","author":"Nalepa","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"R24-20230910","first-page":"34","article-title":"Does the presence of morphine counteract adaptive changes in expression of G-protein alpha subunits mRNA induced by chronic morphine treatment?","volume":"59","author":"Nalepa","year":"2007","journal-title":"Pharmacol Rep"},{"key":"R25-20230910","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S1734-1140(13)71509-3","article-title":"\u03b11-Adrenergic receptor subtypes in the central nervous system: insights from genetically engineered mouse models","volume":"65","author":"Nalepa","year":"2013","journal-title":"Pharmacol Rep"},{"key":"R26-20230910","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00213-004-2048-7","article-title":"Forced swimming test in mice: a review of antidepressant activity","volume":"177","author":"Petit-Demouliere","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"R27-20230910","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"R28-20230910","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0006-3223(99)00041-4","article-title":"Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression","volume":"45","author":"Rajkowska","year":"1999","journal-title":"Biol Psychiatry"},{"key":"R29-20230910","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0014-2999(00)00565-3","article-title":"Antidepressants: past, present and future","volume":"405","author":"Vetulani","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"R30-20230910","doi-asserted-by":"crossref","first-page":"40811","DOI":"10.1074\/jbc.M105572200","article-title":"Different subtypes of \u03b11-adrenoceptor modulate different K+ currents via different signaling pathways in canine ventricular myocytes","volume":"276","author":"Wang","year":"2001","journal-title":"J Biol Chem"},{"key":"R31-20230910","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1021\/jm00010a001","article-title":"Discovery of \u03b11a-adrenergic receptor antagonists based on the L-type Ca2+ channel antagonist niguldipine","volume":"38","author":"Wetzel","year":"1995","journal-title":"J Med Chem"},{"key":"R32-20230910","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/sj.bjp.0702541","article-title":"In vitro \u03b11-adrenoceptor pharmacology of Ro 70-0004 and RS-100329, novel \u03b11A-adrenoceptor selective antagonists","volume":"127","author":"Williams","year":"1999","journal-title":"Br J Pharmacol"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00008877-201606000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T08:02:40Z","timestamp":1694332960000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008877-201606000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0000000000000204","relation":{},"ISSN":["0955-8810"],"issn-type":[{"value":"0955-8810","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]}}}